Dr. Katherine Atkinson, MD

NPI: 1700849643
Total Payments
$8,645
2024 Payments
$449.39
Companies
45
Transactions
341
Medicare Patients
13,205
Medicare Billing
$1.8M

Payment Breakdown by Category

Food & Beverage$6,216 (71.9%)
Other$1,520 (17.6%)
Education$909.00 (10.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $6,216 331 71.9%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,520 2 17.6%
Education $909.00 8 10.5%

Top Paying Companies

Company Total Records Latest Year
Surgi-Care, Inc. $2,260 3 $0 (2019)
Janssen Pharmaceuticals, Inc $1,243 35 $0 (2024)
PFIZER INC. $777.06 69 $0 (2024)
GlaxoSmithKline, LLC. $677.06 46 $0 (2023)
AstraZeneca Pharmaceuticals LP $505.26 25 $0 (2024)
Astellas Pharma US Inc $250.24 9 $0 (2024)
Ironshore Pharmaceuticals Inc. $232.43 3 $0 (2019)
Amgen Inc. $213.67 10 $0 (2022)
Merck Sharp & Dohme LLC $200.03 12 $0 (2024)
Novo Nordisk Inc $179.70 10 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $449.39 16 Janssen Pharmaceuticals, Inc ($134.56)
2023 $1,031 33 Janssen Pharmaceuticals, Inc ($319.03)
2022 $559.59 42 Biohaven Pharmaceutical Holding Company Ltd. ($150.22)
2021 $361.16 19 Janssen Pharmaceuticals, Inc ($90.51)
2020 $870.64 49 Janssen Pharmaceuticals, Inc ($205.16)
2019 $2,223 61 Surgi-Care, Inc. ($780.00)
2018 $1,690 64 Surgi-Care, Inc. ($740.00)
2017 $1,461 57 Surgi-Care, Inc. ($740.00)

All Payment Transactions

341 individual payment records from CMS Open Payments — Page 1 of 14

Date Company Product Nature Form Amount Type
12/12/2024 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $17.31 General
Category: Cardiovascular
11/13/2024 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $26.37 General
Category: Cardiovascular
11/07/2024 Merck Sharp & Dohme LLC GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 Food and Beverage In-kind items and services $26.42 General
Category: VACCINE
10/24/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $20.09 General
Category: Biological
09/17/2024 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $19.10 General
Category: Neuroscience
08/15/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $22.94 General
Category: NEUROSCIENCE
07/18/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $29.29 General
05/09/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $20.00 General
Category: Biological
04/11/2024 Radius Health, Inc. Tymlos (Drug) Food and Beverage In-kind items and services $20.85 General
Category: Endocrinology
03/28/2024 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $115.46 General
Category: Neuroscience
03/28/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $31.52 General
Category: NEUROSCIENCE
02/28/2024 PFIZER INC. TRUMENBA (Biological), PREVNAR 20 Food and Beverage In-kind items and services $20.58 General
Category: VACCINES
02/15/2024 Alkermes, Inc. VIVITROL (Drug) Food and Beverage In-kind items and services $15.29 General
Category: CNS
01/18/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $20.88 General
01/11/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $19.77 General
01/03/2024 Exeltis, USA Inc. SLYND (Drug) Food and Beverage In-kind items and services $23.52 General
Category: CONTRACEPTIVE
12/14/2023 SANOFI PASTEUR INC. BEYFORTUS (Biological), VAXELIS Food and Beverage In-kind items and services $29.18 General
Category: Vaccines
11/30/2023 Myriad Women's Health, Inc. MYRISK (Device) Food and Beverage In-kind items and services $165.59 General
Category: ONCOLOGY
11/16/2023 SANOFI PASTEUR INC. BEYFORTUS (Biological), VAXELIS Food and Beverage In-kind items and services $21.11 General
Category: Vaccines
11/16/2023 Braeburn Inc. BRIXADI (Drug) Food and Beverage In-kind items and services $21.06 General
Category: Opioid Use Disorder
11/02/2023 Merck Sharp & Dohme LLC PROQUAD (Biological), VAXNEUVANCE, GARDASIL 9 Food and Beverage In-kind items and services $23.54 General
Category: VACCINE
10/26/2023 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $108.60 General
Category: Neuroscience
10/18/2023 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $20.17 General
Category: PSYCHIATRY
08/31/2023 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $18.08 General
Category: Cardiovascular
08/28/2023 Gilead Sciences, Inc. Food and Beverage In-kind items and services $28.97 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 45 3,699 9,473 $913,137 $465,954
2022 44 3,190 7,789 $777,647 $392,979
2021 43 3,423 8,430 $951,967 $490,778
2020 34 2,893 8,318 $1.1M $472,839
Total Patients
13,205
Total Services
34,010
Medicare Billing
$1.8M
Procedure Codes
166

All Medicare Procedures & Services

166 procedure records from CMS Medicare Utilization — Page 1 of 7

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 418 1,472 $279,680 $140,841 50.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 313 313 $87,640 $42,236 48.2%
97124 Therapy procedure using massage, each 15 minutes Office 2023 80 1,948 $97,400 $36,774 37.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 132 256 $64,000 $36,508 57.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 287 529 $66,125 $35,662 53.9%
91320 Sarscv2 vac 30mcg trs-suc im Office 2023 185 186 $28,100 $23,897 85.0%
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 136 411 $61,380 $21,093 34.4%
J0897 Injection, denosumab, 1 mg Office 2023 19 1,686 $30,806 $19,842 64.4%
99497 Advance care planning, first 30 minutes Office 2023 202 203 $22,330 $16,697 74.8%
90662 Influenza vaccine split virus, preservative free Office 2023 195 195 $16,515 $14,016 84.9%
90480 Admn sarscov2 vacc 1 dose Office 2023 185 186 $18,600 $7,803 41.9%
G0008 Administration of influenza virus vaccine Office 2023 219 220 $10,340 $6,923 67.0%
99487 Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 33 61 $12,200 $6,643 54.5%
90671 Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use Office 2023 24 24 $6,000 $5,549 92.5%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2023 31 31 $8,680 $5,347 61.6%
0124A Adm sarscv2 bvl 30mcg/.3ml a Office 2023 127 127 $12,700 $5,286 41.6%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2023 17 17 $5,100 $4,809 94.3%
90732 Pneumococcal vaccine, 23-valent Office 2023 37 37 $4,415 $4,327 98.0%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2023 35 38 $5,700 $4,025 70.6%
99489 Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 16 63 $6,930 $3,684 53.2%
87811 Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) Office 2023 67 82 $8,200 $3,285 40.1%
G0506 Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) Office 2023 72 72 $6,480 $3,133 48.4%
G0009 Administration of pneumococcal vaccine Office 2023 71 71 $3,337 $2,234 67.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 15 15 $4,125 $1,935 46.9%
96372 Injection of drug or substance under skin or into muscle Office 2023 50 142 $6,390 $1,602 25.1%

About Dr. Katherine Atkinson, MD

Dr. Katherine Atkinson, MD is a Family Medicine healthcare provider based in Amherst, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700849643.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Katherine Atkinson, MD has received a total of $8,645 in payments from pharmaceutical and medical device companies, with $449.39 received in 2024. These payments were reported across 341 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($6,216).

As a Medicare-enrolled provider, Atkinson has provided services to 13,205 Medicare beneficiaries, totaling 34,010 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 166 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Amherst, MA
  • Active Since 04/11/2006
  • Last Updated 04/25/2018
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1700849643

Products in Payments

  • SPRAVATO (Drug) $667.93
  • CHANTIX (Drug) $538.95
  • XARELTO (Drug) $469.92
  • FARXIGA (Drug) $320.08
  • Jornay PM 20mg capsules (Bottle of 100) (Drug) $232.43
  • SHINGRIX (Biological) $228.46
  • NURTEC ODT (Drug) $186.16
  • TRELEGY ELLIPTA (Drug) $173.50
  • MYRISK (Device) $165.59
  • ELIQUIS (Drug) $150.51
  • BREO (Drug) $138.29
  • INTRAROSA (Drug) $129.80
  • INVOKANA (Drug) $105.05
  • Aimovig (Biological) $102.07
  • UBRELVY (Drug) $91.65
  • JARDIANCE (Drug) $80.55
  • VRAYLAR (Drug) $78.60
  • MYRBETRIQ (Drug) $76.68
  • BEXSERO (Biological) $72.84
  • REXULTI (Drug) $65.73

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Amherst